Q32 Bio (QTTB) Operating Expenses (2017 - 2026)

Q32 Bio's Operating Expenses history runs 10 years deep, the most recent figure standing at $7.7 million for Q1 2026.

• On a quarterly basis, Operating Expenses fell 36.85% year-over-year to $7.7 million in Q1 2026; TTM through Mar 2026 was $32.3 million, a 49.08% decrease from a year earlier, with the FY2025 full-year figure at $36.8 million, down 44.28% from the prior year.
• Operating Expenses fell to $7.7 million in Q1 2026 per QTTB's latest filing, from $7.9 million in the prior quarter.
• Across five years, Operating Expenses topped out at $38.4 million in Q1 2022 and bottomed at $7.6 million in Q3 2025.
• The 5-year median for Operating Expenses is $12.2 million (2025), against an average of $17.0 million.
• Across the five-year window, Operating Expenses sank 73.14% in 2023 and jumped 94.82% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $35.3 million in 2022, then tumbled by 68.42% to $11.1 million in 2023, then surged by 30.31% to $14.5 million in 2024, then sank by 45.9% to $7.9 million in 2025, then retreated by 1.73% to $7.7 million in 2026.
• Per Business Quant, the three latest QTTB Operating Expenses figures stand at $7.7 million (Q1 2026), $7.9 million (Q4 2025), and $7.6 million (Q3 2025).